File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/MCP.0b013e32834feae7
- Scopus: eid_2-s2.0-84856634404
- PMID: 22262139
- WOS: WOS:000300187200003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease
Title | Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease |
---|---|
Authors | |
Keywords | COPD pulmonary function testing screening |
Issue Date | 2012 |
Publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.com |
Citation | Current Opinion In Pulmonary Medicine, 2012, v. 18 n. 2, p. 104-111 How to Cite? |
Abstract | PURPOSE OF REVIEW: The purpose of this review article is to provide an up-to-date summary on the current evidence for or against the use of lung function tests as screening and diagnostic tools for airflow obstruction in chronic obstructive pulmonary disease (COPD), and to consider the relevant issues in context. RECENT FINDINGS: COPD is characterized by chronic respiratory symptoms and airflow limitation with only partial reversibility on lung function testing. However, screening on a population basis or of an enriched 'at-risk' subset like chronic smokers is not supported by findings from previous epidemiological studies, screening trials or in currently published clinical management guidelines by professional societies and review bodies. The definition of airflow obstruction and the classification of disease severity of COPD also differ slightly between guidelines and statements from different professional societies. SUMMARY: Given the experience from previous screening trials and controversial classification of airflow obstruction by severity, it is impossible to have accurate screening results for COPD based on lung function tests alone. Clinical respiratory symptoms should be taken into consideration in terms of the diagnosis and management of COPD, as well as in any screening trial or programme that is to be attempted or implemented. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins. |
Persistent Identifier | http://hdl.handle.net/10722/163454 |
ISSN | 2021 Impact Factor: 2.868 2020 SCImago Journal Rankings: 0.937 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lam, DCL | en_US |
dc.contributor.author | Hui, CKM | en_US |
dc.contributor.author | Ip, MSM | en_US |
dc.date.accessioned | 2012-09-05T05:31:36Z | - |
dc.date.available | 2012-09-05T05:31:36Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.citation | Current Opinion In Pulmonary Medicine, 2012, v. 18 n. 2, p. 104-111 | en_US |
dc.identifier.issn | 1070-5287 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/163454 | - |
dc.description.abstract | PURPOSE OF REVIEW: The purpose of this review article is to provide an up-to-date summary on the current evidence for or against the use of lung function tests as screening and diagnostic tools for airflow obstruction in chronic obstructive pulmonary disease (COPD), and to consider the relevant issues in context. RECENT FINDINGS: COPD is characterized by chronic respiratory symptoms and airflow limitation with only partial reversibility on lung function testing. However, screening on a population basis or of an enriched 'at-risk' subset like chronic smokers is not supported by findings from previous epidemiological studies, screening trials or in currently published clinical management guidelines by professional societies and review bodies. The definition of airflow obstruction and the classification of disease severity of COPD also differ slightly between guidelines and statements from different professional societies. SUMMARY: Given the experience from previous screening trials and controversial classification of airflow obstruction by severity, it is impossible to have accurate screening results for COPD based on lung function tests alone. Clinical respiratory symptoms should be taken into consideration in terms of the diagnosis and management of COPD, as well as in any screening trial or programme that is to be attempted or implemented. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins. | en_US |
dc.language | eng | en_US |
dc.publisher | Lippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.com | en_US |
dc.relation.ispartof | Current Opinion in Pulmonary Medicine | en_US |
dc.subject | COPD | - |
dc.subject | pulmonary function testing | - |
dc.subject | screening | - |
dc.title | Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease | en_US |
dc.type | Article | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1097/MCP.0b013e32834feae7 | en_US |
dc.identifier.pmid | 22262139 | - |
dc.identifier.scopus | eid_2-s2.0-84856634404 | en_US |
dc.identifier.hkuros | 202196 | - |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 104 | en_US |
dc.identifier.epage | 111 | en_US |
dc.identifier.isi | WOS:000300187200003 | - |
dc.publisher.place | United States | en_US |
dc.identifier.issnl | 1070-5287 | - |